Research ExplorerPublicationsTrends of retroperitoneal lymphadenectomy use in patients wi...

Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study.

Standard

Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study. / Sun, Maxine; Abdollah, Firas; Budäus, Lars; Liberman, Daniel; Tian, Zhe; Morgan, Monica; Johal, Rupinder; Schmitges, Jan; Shariat, Shahrokh F; Montorsi, Francesco; Graefen, Markus; Perrotte, Paul; Karakiewicz, Pierre I.

In: ANN SURG ONCOL, Vol. 18, No. 10, 10, 2011, p. 2997-3004.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Sun, M, Abdollah, F, Budäus, L, Liberman, D, Tian, Z, Morgan, M, Johal, R, Schmitges, J, Shariat, SF, Montorsi, F, Graefen, M, Perrotte, P & Karakiewicz, PI 2011, 'Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study.', ANN SURG ONCOL, vol. 18, no. 10, 10, pp. 2997-3004. <http://www.ncbi.nlm.nih.gov/pubmed/21509630?dopt=Citation>

APA

Sun, M., Abdollah, F., Budäus, L., Liberman, D., Tian, Z., Morgan, M., Johal, R., Schmitges, J., Shariat, S. F., Montorsi, F., Graefen, M., Perrotte, P., & Karakiewicz, P. I. (2011). Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study. ANN SURG ONCOL, 18(10), 2997-3004. [10]. http://www.ncbi.nlm.nih.gov/pubmed/21509630?dopt=Citation

Vancouver

Sun M, Abdollah F, Budäus L, Liberman D, Tian Z, Morgan M et al. Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study. ANN SURG ONCOL. 2011;18(10):2997-3004. 10.

Bibtex

@article{4b1d9c4171fc4c308c863706d2179f5e,
title = "Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study.",
abstract = "Retroperitoneal lymphadenectomy (RPLND), chemotherapy, and active surveillance represent treatment options for patients with nonseminomatous germ-cell tumors of the testis (NSGCTT). Our objective was to assess the utilization rate of RPLND in patients with NSGCTT.",
keywords = "Adult, Humans, Male, Cohort Studies, Lymphatic Metastasis, Prognosis, Survival Rate, Follow-Up Studies, Postoperative Complications, Neoplasm Staging, United States/epidemiology, Lymph Node Excision/*utilization, Mortality/*trends, Neoplasms, Germ Cell and Embryonal/*epidemiology/mortality/*surgery, Retroperitoneal Space/*surgery, SEER Program, Testicular Neoplasms/*epidemiology/mortality/*surgery, Adult, Humans, Male, Cohort Studies, Lymphatic Metastasis, Prognosis, Survival Rate, Follow-Up Studies, Postoperative Complications, Neoplasm Staging, United States/epidemiology, Lymph Node Excision/*utilization, Mortality/*trends, Neoplasms, Germ Cell and Embryonal/*epidemiology/mortality/*surgery, Retroperitoneal Space/*surgery, SEER Program, Testicular Neoplasms/*epidemiology/mortality/*surgery",
author = "Maxine Sun and Firas Abdollah and Lars Bud{\"a}us and Daniel Liberman and Zhe Tian and Monica Morgan and Rupinder Johal and Jan Schmitges and Shariat, {Shahrokh F} and Francesco Montorsi and Markus Graefen and Paul Perrotte and Karakiewicz, {Pierre I}",
year = "2011",
language = "English",
volume = "18",
pages = "2997--3004",
journal = "ANN SURG ONCOL",
issn = "1068-9265",
publisher = "Springer New York",
number = "10",

}

RIS

TY - JOUR

T1 - Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study.

AU - Sun, Maxine

AU - Abdollah, Firas

AU - Budäus, Lars

AU - Liberman, Daniel

AU - Tian, Zhe

AU - Morgan, Monica

AU - Johal, Rupinder

AU - Schmitges, Jan

AU - Shariat, Shahrokh F

AU - Montorsi, Francesco

AU - Graefen, Markus

AU - Perrotte, Paul

AU - Karakiewicz, Pierre I

PY - 2011

Y1 - 2011

N2 - Retroperitoneal lymphadenectomy (RPLND), chemotherapy, and active surveillance represent treatment options for patients with nonseminomatous germ-cell tumors of the testis (NSGCTT). Our objective was to assess the utilization rate of RPLND in patients with NSGCTT.

AB - Retroperitoneal lymphadenectomy (RPLND), chemotherapy, and active surveillance represent treatment options for patients with nonseminomatous germ-cell tumors of the testis (NSGCTT). Our objective was to assess the utilization rate of RPLND in patients with NSGCTT.

KW - Adult

KW - Humans

KW - Male

KW - Cohort Studies

KW - Lymphatic Metastasis

KW - Prognosis

KW - Survival Rate

KW - Follow-Up Studies

KW - Postoperative Complications

KW - Neoplasm Staging

KW - United States/epidemiology

KW - Lymph Node Excision/utilization

KW - Mortality/trends

KW - Neoplasms, Germ Cell and Embryonal/epidemiology/mortality/surgery

KW - Retroperitoneal Space/surgery

KW - SEER Program

KW - Testicular Neoplasms/epidemiology/mortality/surgery

KW - Adult

KW - Humans

KW - Male

KW - Cohort Studies

KW - Lymphatic Metastasis

KW - Prognosis

KW - Survival Rate

KW - Follow-Up Studies

KW - Postoperative Complications

KW - Neoplasm Staging

KW - United States/epidemiology

KW - Lymph Node Excision/utilization

KW - Mortality/trends

KW - Neoplasms, Germ Cell and Embryonal/epidemiology/mortality/surgery

KW - Retroperitoneal Space/surgery

KW - SEER Program

KW - Testicular Neoplasms/epidemiology/mortality/surgery

M3 - SCORING: Journal article

VL - 18

SP - 2997

EP - 3004

JO - ANN SURG ONCOL

JF - ANN SURG ONCOL

SN - 1068-9265

IS - 10

M1 - 10

ER -